Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 1/20 | 0.34 |
| ▸ | KDM1A | O60341 | 4/20 | 0.33 |
| ▸ | TGFBR1 | P36897 | 3/20 | 0.32 |
| ▸ | CDK9 | P50750 | 1/20 | 0.31 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.31 |
| ▸ | DYRK2 | Q92630 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
| ▸ | HTT | P42858 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19687598 | 0.86 | RAB9A (0.35) | RAB9ATGFBR1LMNAMAPTTSHR | |
| SCHEMBL19687578 | 0.80 | KDM1A (0.39) | RAB9AKDM1ALMNAMAPTHTT | |
| SCHEMBL19687618 | 0.73 | RAB9A (0.32) | RAB9A | |
| SCHEMBL25726488 | 0.67 | PARG (0.30) | — | |
| SCHEMBL19687576 | 0.67 | RAB9A (0.35) | RAB9ALMNATSHR | |
| SCHEMBL19687583 | 0.65 | MEN1 (0.43) | RAB9ALMNAMAPTTSHR | |
| SCHEMBL14231639 | 0.65 | PGR (0.31) | — | |
| SCHEMBL19687591 | 0.63 | MEN1 (0.43) | RAB9AKDM1AMAPTTSHR | |
| SCHEMBL19687593 | 0.63 | POLB (0.41) | RAB9ADYRK1ALMNAHTT | |
| SCHEMBL19295052 | 0.61 | MEN1 (0.39) | RAB9ALMNAMAPTTSHRHTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2017205972-A1 | SYSTEMS METHODS AND COMPOSITIONS FOR PREDICTING METASTASIS IN BLADDER CANCER | GENOMEDX BIOSCIENCES, INC. (CA) | 2017-12-07 | — | — | WO | disclosed |